Porphyria cutanea tarda is a metabolic disorder caused by reduced hepa
tic uroporphyrinogen decarboxylase activity characterized by skin lesi
ons and liver damage. The high frequency of liver histological damage
in patients with porphyria cutanea tarda led us to study hepatitis B a
nd C viral infection which has a striking prevalence in southern Europ
e. We attempt here to expose different pathophysiological hypotheses:
is viral hepatitis a triggering factor precipiting latent decreased ur
oporphyrinogen decarboxylase activity or does it directly induce the e
nzyme deficiency?